ES525246A0 - Metodo para estabilizar un concentrado de gamma globulina - Google Patents

Metodo para estabilizar un concentrado de gamma globulina

Info

Publication number
ES525246A0
ES525246A0 ES525246A ES525246A ES525246A0 ES 525246 A0 ES525246 A0 ES 525246A0 ES 525246 A ES525246 A ES 525246A ES 525246 A ES525246 A ES 525246A ES 525246 A0 ES525246 A0 ES 525246A0
Authority
ES
Spain
Prior art keywords
stabilizing
gamma globulin
globulin concentrate
concentrate
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES525246A
Other languages
English (en)
Other versions
ES8507567A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Travenol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Laboratories Inc filed Critical Baxter Travenol Laboratories Inc
Publication of ES8507567A1 publication Critical patent/ES8507567A1/es
Publication of ES525246A0 publication Critical patent/ES525246A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES525246A 1982-08-30 1983-08-30 Metodo para estabilizar un concentrado de gamma globulina Granted ES525246A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/413,060 US4439421A (en) 1982-08-30 1982-08-30 Stabilized gamma globulin concentrate

Publications (2)

Publication Number Publication Date
ES8507567A1 ES8507567A1 (es) 1985-09-01
ES525246A0 true ES525246A0 (es) 1985-09-01

Family

ID=23635660

Family Applications (1)

Application Number Title Priority Date Filing Date
ES525246A Granted ES525246A0 (es) 1982-08-30 1983-08-30 Metodo para estabilizar un concentrado de gamma globulina

Country Status (8)

Country Link
US (1) US4439421A (es)
EP (1) EP0118462B1 (es)
JP (1) JPH07116058B2 (es)
CA (1) CA1219211A (es)
DE (1) DE3382419D1 (es)
ES (1) ES525246A0 (es)
IT (1) IT1169789B (es)
WO (1) WO1984000890A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0116571B2 (en) * 1982-08-30 1997-10-29 BAXTER INTERNATIONAL INC. (a Delaware corporation) Method for making gamma globulin-containing compositions
US4650772A (en) * 1984-08-09 1987-03-17 Abbott Laboratories Monoclonal antibody stabilization
US4597966A (en) * 1985-01-09 1986-07-01 Ortho Diagnostic Systems, Inc. Histidine stabilized immunoglobulin and method of preparation
CA1310267C (en) * 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
JP2547556B2 (ja) * 1987-02-06 1996-10-23 株式会社 ミドリ十字 ｒ−グロブリンの液状製剤
DE3877015T2 (de) * 1987-02-20 1993-05-06 Akzo Nv Antikoerper enthaltende stabilisierte waesserige zusammensetzung.
US5237054A (en) * 1987-02-20 1993-08-17 Akzo Pharma Stabilized aqueous composition containing antibodies
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
AU2309692A (en) * 1991-07-03 1993-02-11 Cryolife, Inc. Method for stabilization of biomaterials
IT1256621B (it) * 1992-12-04 1995-12-12 Soluzioni crioprotettrici
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US6685940B2 (en) 1995-07-27 2004-02-03 Genentech, Inc. Protein formulation
EP0852951A1 (de) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
RU2155069C1 (ru) * 1999-02-02 2000-08-27 Государственное унитарное предприятие "Иммунопрепарат" Способ получения иммуноглобулина для внутривенного введения и его варианты
EP1280576B1 (en) * 2000-04-03 2010-05-05 Battelle Memorial Institute Dispensing devices and liquid formulations
AU3664102A (en) * 2000-12-01 2002-06-11 Battelle Memorial Institute Method for stabilizing biomolecules in liquid formulations
EP1532983A1 (en) * 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
TWI489994B (zh) 2008-03-17 2015-07-01 Baxter Healthcare Sa 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
MX2012003282A (es) 2009-09-17 2012-04-30 Baxter Healthcare Sa Co-formulacion estable de hialuronidasa e inmunoglobulina, y metodos de su uso.
DK2531218T3 (en) 2010-02-04 2019-04-01 Csl Behring Ag immunoglobulin
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
ES2825704T3 (es) 2014-12-03 2021-05-17 Csl Behring Ag Producto farmacéutico con mayor estabilidad que comprende inmunoglobulinas

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966906A (en) * 1961-10-11 1976-06-29 Behringwerke Aktiengesellschaft Disaggregated gamma globulin and process for preparing it
US3105012A (en) * 1961-10-19 1963-09-24 Parke Davis & Co Antigen products and means for producing the same
NL286954A (es) * 1962-01-03
JPS52960B2 (es) * 1971-08-26 1977-01-11
DE2364792A1 (de) * 1973-01-15 1974-07-18 South African Inventions Verfahren zum reinigen von gammaglobulin
CH566798A5 (es) * 1973-05-29 1975-09-30 Battelle Memorial Institute
FR2267115B1 (es) * 1974-04-12 1977-11-10 Merieux Inst
CA1064396A (en) * 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
US4126605A (en) * 1975-12-29 1978-11-21 Plasmesco Ag Process of improving the compatibility of gamma globulins
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
DE2801123C2 (de) * 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
DE2835843A1 (de) * 1978-08-16 1980-02-28 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
EP0116571B2 (en) * 1982-08-30 1997-10-29 BAXTER INTERNATIONAL INC. (a Delaware corporation) Method for making gamma globulin-containing compositions

Also Published As

Publication number Publication date
US4439421A (en) 1984-03-27
ES8507567A1 (es) 1985-09-01
JPS59501547A (ja) 1984-08-30
DE3382419D1 (de) 1991-10-31
CA1219211A (en) 1987-03-17
EP0118462B1 (en) 1991-09-25
EP0118462A1 (en) 1984-09-19
IT1169789B (it) 1987-06-03
IT8322666A0 (it) 1983-08-29
WO1984000890A1 (en) 1984-03-15
EP0118462A4 (en) 1986-03-18
JPH07116058B2 (ja) 1995-12-13

Similar Documents

Publication Publication Date Title
ES525246A0 (es) Metodo para estabilizar un concentrado de gamma globulina
ES538803A0 (es) Un metodo para tratar un concentrado de fibrinogeno
KR840005446A (ko) N--4-피페리딘아민의 제조방법
IT1167585B (it) Attrezzo per posizionare esattamente un oggetto
ES523419A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona
DK183583D0 (da) Fremgangsmade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner
ES530017A0 (es) Un metodo para preparar derivados de 3-metilflavona
ES535381A0 (es) Un metodo para preparar un derivado de azuleno
DK159309C (da) Fremgangsmaade til fremstilling af 4-metyl-5-alkylthiometyl-imidazoler
ES529034A0 (es) Un metodo para preparar nuevos compuestos de benzoilurea
ES521389A0 (es) Un metodo para preparar derivados de tiazolidina.
ES534355A0 (es) Un metodo para preparar derivados de fenotiazina
RO86512A (ro) Procedeu de scindare a trans-dl-1-n-propil-6-o0odecahidrochinolinei
DK40883D0 (da) Fremgangsmade til fremstilling af benzothienylallylaminer
GB8320259D0 (en) Positioning method
BR8302248A (pt) Metodo para conservar tecido
DK457983D0 (da) Fremgangsmade til fremstilling af beta-lactam
DK518883A (da) Fremgangsmaade til fremstilling af 1-oxa-beta-lactam-forbindelser
DK399783A (da) Fremgangsmaade til fremstilling af substituerede 1-pyridyloxy-3-indolylalkylamino-2-propanoler
KR840004092A (ko) N-치환-테트라하이드로티아진의 제조방법
DK299083A (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser
DK432683D0 (da) Fremgangsmade til fremstilling af 2-hydroxy-2-phenylethylaminer
DK535083A (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser
ES536997A0 (es) Un metodo para holografiar un objeto
DK30784A (da) Konditioneringsgaranti for stroedaaser med afloebsroer af sifontype

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040402